Cardioprotective therapies such as statins and antiplatelet agents are underutilised in patients with cancer, an Australian study has shown. A retrospective review of medical records of 320 patients admitted to the cardiology unit at John Hunter Hospital in 2018 and 2019 found that patients with a history of cancer who had an indication for cardioprotective ...
Cancer patients miss out on cardioprotective therapies
By Michael Woodhead
23 Jun 2020